Consensus Statements on Airway Clearance Interventions in Intubated Critically Ill Patients--Protocol for a Delphi Study
Launched by ACADEMISCH MEDISCH CENTRUM - UNIVERSITEIT VAN AMSTERDAM (AMC-UVA) · Oct 17, 2024
Trial Information
Current as of July 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how to best clear mucus from the airways of critically ill patients who are on ventilators. When patients are intubated (which means they have a tube in their throat to help them breathe), mucus can build up and make it harder for them to breathe. Different methods, like using humidifiers or suctioning, are used to help clear this mucus, but there isn't a clear agreement on which methods work best. This study will gather opinions from healthcare professionals around the world to understand which airway clearance techniques they believe are most effective.
To participate in this study, healthcare professionals need to have at least five years of experience caring for patients on ventilators and should have contributed to guidelines or published research in this area. The researchers want a diverse group of panelists, considering both gender and geographical background. While this trial is not yet recruiting participants, it aims to create a consensus on the best practices for managing airway clearance in critically ill patients, which could lead to improved care and outcomes for these patients.
Gender
ALL
Eligibility criteria
- Healthcare professionals will be selected as panelists based on the following criteria:
- Inclusion criteria:
- • at least 5 years of clinical experience, with care for invasively ventilated patients (teaching and non-teaching); and
- • participation in development of a guideline or authorship of at least one peer reviewed published paper in airway care for invasive ventilated patients; and
- • not more than 70% of the panelists from each sex; and from each of high and low- and middle-income countries.
- Exclusion criteria:
- • - none
- • Purposive sampling will be utilized to recruit panelists by reviewing recent publications in the field of airway care for invasive ventilated patients. Selection of panelists will be guided by predefined criteria, with deliberate efforts to ensure a balance in gender and geographical representation.
About Academisch Medisch Centrum Universiteit Van Amsterdam (Amc Uva)
The Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) is a leading academic medical center in the Netherlands, dedicated to advancing healthcare through innovative research, education, and patient care. Affiliated with the University of Amsterdam, AMC-UvA integrates clinical practice with cutting-edge biomedical research, fostering a multidisciplinary approach to medical challenges. The institution actively engages in clinical trials to enhance treatment options and improve patient outcomes, while promoting collaboration among healthcare professionals, researchers, and academic institutions globally. With a commitment to excellence and a focus on translational medicine, AMC-UvA plays a pivotal role in shaping the future of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Frederique Paulus, prof. dr.
Principal Investigator
Amsterdam UMC
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported